Health Insurance Marketplace SM, 37593-37595 [2017-16979]

Download as PDF asabaliauskas on DSKBBXCHB2PROD with NOTICES Federal Register / Vol. 82, No. 154 / Friday, August 11, 2017 / Notices Guidance/Legislation/Paperwork ReductionActof1995/PRA-Listing.html. 2. Email your request, including your address, phone number, OMB number, and CMS document identifier, to Paperwork@cms.hhs.gov. 3. Call the Reports Clearance Office at (410) 786–1326. FOR FURTHER INFORMATION CONTACT: William Parham at (410) 786–4669. SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501–3520), Federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. The term ‘‘collection of information’’ is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and includes agency requests or requirements that members of the public submit reports, keep records, or provide information to a third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A)) requires Federal agencies to publish a 30-day notice in the Federal Register concerning each proposed collection of information, including each proposed extension or reinstatement of an existing collection of information, before submitting the collection to OMB for approval. No comments were received in response to the 60-day comment period. To comply with this requirement, CMS is publishing this notice that summarizes the following proposed collection(s) of information for public comment: 1. Type of Information Collection Request: Revision of a currently approved collection; Title of Information Collection: Disclosure of State Rating Requirements; Use: The final rule ‘‘Patient Protection and Affordable Care Act; Health Insurance Market Rules; Rate Review’’ implements sections 2701, 2702, and 2703 of the Public Health Service Act (PHS Act), as added and amended by the Affordable Care Act, and sections 1302(e) and 1312(c) of the Affordable Care Act. The rule directs that states submit to CMS certain information about state rating and risk pooling requirements for their individual, small group, and large group markets, as applicable. Specifically, states will inform CMS of age rating ratios that are narrower than 3:1 for adults; tobacco use rating ratios that are narrower than 1.5:1; a state-established uniform age curve; geographic rating areas; whether premiums in the small and large group market are required to be based on average enrollee amounts (also known as composite premiums); and, in states that do not permit any rating variation based on age or tobacco use, uniform family tier structures and VerDate Sep<11>2014 17:18 Aug 10, 2017 Jkt 241001 corresponding multipliers. In addition, states that elect to merge their individual and small group market risk pools into a combined pool will notify CMS of such election. This information will allow CMS to determine whether state-specific rules apply or Federal default rules apply. It will also support the accuracy of the Federal risk adjustment methodology. Form Number: CMS–10454 (OMB control number: 0938–1258); Frequency: On Occasion; Affected Public: State, Local, or Tribal Governments, Private Sector; Number of Respondents: 47; Total Annual Responses: 47; Total Annual Hours: 2,239. (For policy questions regarding this collection contact Russell Tipps at 301–492–4371.) Dated: August 8, 2017. William N. Parham, III, Director, Paperwork Reduction Staff Office of Strategic Operations and Regulatory Affairs. [FR Doc. 2017–17020 Filed 8–10–17; 8:45 am] BILLING CODE 4120–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [CMS–7046–N] Health Insurance Marketplace SM, Medicare, Medicaid, and Children’s Health Insurance Programs; Meeting of the Advisory Panel on Outreach and Education (APOE), September 13, 2017 Centers for Medicare & Medicaid Services (CMS), HHS. ACTION: Notice. AGENCY: This notice announces the next meeting of the Advisory Panel on Outreach and Education (APOE) (the Panel) in accordance with the Federal Advisory Committee Act. The Panel advises and makes recommendations to the Secretary of the U.S. Department of Health and Human Services (HHS) and the Administrator of the Centers for Medicare & Medicaid Services (CMS) on opportunities to enhance the effectiveness of consumer education strategies concerning the Health Insurance Marketplace SM, Medicare, Medicaid, and the Children’s Health Insurance Program (CHIP). This meeting is open to the public. DATES: Meeting Date: Wednesday, September 13, 2017, 8:30 a.m. to 4:00 p.m. eastern daylight time (e.d.t). Deadline for Meeting Registration, Presentations, Special Accommodations and Comments: Wednesday, August 30, 2017, 5:00 p.m. (e.d.t.). SUMMARY: PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 37593 Meeting Location: U.S. Department of Health & Human Services, Hubert H. Humphrey Building, 200 Independence Avenue SW., Room 505A, Conference Room, Washington, DC 20201. Presentations and Written Comments: Presentations and written comments should be submitted to: Thomas Dudley, Designated Federal Official (DFO), Office of Communications, Centers for Medicare & Medicaid Services, 7500 Security Boulevard, Mailstop S1–05–06, Baltimore, MD 21244–1850 or via email at Thomas.Dudley@cms.hhs.gov. Registration: The meeting is open to the public, but attendance is limited to the space available. Persons wishing to attend this meeting must register at the Web site https://www.regonline.com/ apoesept2017meeting or by contacting the DFO as listed in the FOR FURTHER INFORMATION CONTACT section of this notice, by the date listed in the DATES section of this notice. Individuals requiring sign language interpretation or other special accommodations should contact the DFO at the address listed in the ADDRESSES section of this notice by the date listed in the DATES section of this notice. FOR FURTHER INFORMATION CONTACT: Thomas Dudley, Designated Federal Official, Office of Communications, CMS, 7500 Security Boulevard, Mail Stop S1–05–06, Baltimore, MD 21244– 1850, 410–786–1442, email Thomas.Dudley@cms.hhs.gov. Additional information about the APOE is available on the Internet at: http:// www.cms.gov/Regulations-andGuidance/Guidance/FACA/APOE.html. Press inquiries are handled through the CMS Press Office at (202) 690–6145. SUPPLEMENTARY INFORMATION: ADDRESSES: I. Background The Advisory Panel for Outreach and Education (APOE) (the Panel) is governed by the provisions of Federal Advisory Committee Act (FACA) (Pub. L. 92–463), as amended (5 U.S.C. App. 2), which sets forth standards for the formation and use of federal advisory committees. The Panel is authorized by section 1114(f) of the Social Security Act (42 U.S.C. 1314(f)) and section 222 of the Public Health Service Act (42 U.S.C. 217a). The Secretary of the U.S. Department of Health and Human Services (HHS) (the Secretary) signed the charter establishing the Citizen’s Advisory Panel on Medicare Education 1 (the 1 We note that the Citizen’s Advisory Panel on Medicare Education is also referred to as the Advisory Panel on Medicare Education (65 FR E:\FR\FM\11AUN1.SGM Continued 11AUN1 asabaliauskas on DSKBBXCHB2PROD with NOTICES 37594 Federal Register / Vol. 82, No. 154 / Friday, August 11, 2017 / Notices predecessor to the APOE) on January 21, 1999 (64 FR 7899, February 17, 1999) to advise and make recommendations to the Secretary and the Administrator of the Centers for Medicare & Medicaid Services (CMS) on the effective implementation of national Medicare education programs, including with respect to the Medicare+Choice (M+C) program added by the Balanced Budget Act of 1997 (Pub. L. 105–33). The Medicare Modernization Act of 2003 (MMA) (Pub. L. 108–173) expanded the existing health plan options and benefits available under the M+C program and renamed it the Medicare Advantage (MA) program. We have had substantial responsibilities to provide information to Medicare beneficiaries about the range of health plan options available and better tools to evaluate these options. The successful MA program implementation required CMS to consider the views and policy input from a variety of private sector constituents and to develop a broad range of public-private partnerships. In addition, Title I of the MMA authorized the Secretary and the Administrator of CMS (by delegation) to establish the Medicare prescription drug benefit. The drug benefit allows beneficiaries to obtain qualified prescription drug coverage. In order to effectively administer the MA program and the Medicare prescription drug benefit, we have substantial responsibilities to provide information to Medicare beneficiaries about the range of health plan options and benefits available, and to develop better tools to evaluate these plans and benefits. The Affordable Care Act (Patient Protection and Affordable Care Act, Public Law 111–148, and Health Care and Education Reconciliation Act of 2010, Public Law 111–152) expanded the availability of other options for health care coverage and enacted a number of changes to Medicare as well as to Medicaid and the Children’s Health Insurance Program (CHIP). Qualified individuals and qualified employers are now able to purchase private health insurance coverage through a competitive marketplace, called an Affordable Insurance Exchange (also called Health Insurance MarketplaceSM,2 or MarketplaceSM). In order to effectively implement and administer these changes, we must 4617). The name was updated in the Second Amended Charter approved on July 24, 2000. 2 Health Insurance MarketplaceSM and MarketplaceSM are service marks of the U.S. Department of Health & Human Services. VerDate Sep<11>2014 17:18 Aug 10, 2017 Jkt 241001 provide information to consumers, providers, and other stakeholders through education and outreach programs regarding how existing programs will change and the expanded range of health coverage options available, including private health insurance coverage through the MarketplaceSM. The APOE allows us to consider a broad range of views and information from interested audiences in connection with this effort and to identify opportunities to enhance the effectiveness of education strategies concerning the Affordable Care Act. The scope of this panel also includes advising on issues pertaining to the education of providers and stakeholders with respect to the Affordable Care Act and certain provisions of the Health Information Technology for Economic and Clinical Health (HITECH) Act enacted as part of the American Recovery and Reinvestment Act of 2009 (ARRA). On January 21, 2011, the Panel’s charter was renewed and the Panel was renamed the Advisory Panel for Outreach and Education. The Panel’s charter was most recently renewed on January 19, 2017, and will terminate on January 19, 2019 unless renewed by appropriate action. Under the current charter, the APOE will advise the Secretary and the Administrator on optimal strategies for the following: • Developing and implementing education and outreach programs for individuals enrolled in, or eligible for, Medicare, Medicaid, and the Children’s Health Insurance Program (CHIP), or coverage available through the Health Insurance MarketplaceSM and other CMS programs. • Enhancing the federal government’s effectiveness in informing Health Insurance MarketplaceSM, Medicare, Medicaid, and CHIP consumers, issuers, providers, and stakeholders, through education and outreach programs, on issues regarding these programs, including the appropriate use of publicprivate partnerships to leverage the resources of the private sector in educating beneficiaries, providers, and stakeholders. • Expanding outreach to vulnerable and underserved communities, including racial and ethnic minorities, in the context of Health Insurance MarketplaceSM, Medicare, Medicaid, and CHIP education programs and other CMS programs as designated. • Assembling and sharing an information base of ‘‘best practices’’ for helping consumers evaluate health coverage options. PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 • Building and leveraging existing community infrastructures for information, counseling, and assistance. • Drawing the program link between outreach and education, promoting consumer understanding of health care coverage choices, and facilitating consumer selection/enrollment, which in turn support the overarching goal of improved access to quality care, including prevention services, envisioned under the Affordable Care Act. The current members of the Panel are: Kellan Baker, Associate Director, Center for American Progress; Robert Blancato, President, Matz, Blancato & Associates; Dale Blasier, Professor of Orthopaedic Surgery, Department of Orthopaedics, Arkansas Children’s Hospital; Deborah Britt, Executive Director of Community & Public Relations, Piedmont Fayette Hospital; Deena Chisolm, Associate Professor of Pediatrics & Public Health, The Ohio State University, Nationwide Children’s Hospital; Josephine DeLeon, Director, Anti-Poverty Initiatives, Catholic Charities of California; Robert Espinoza, Vice President of Policy, Paraprofessional Healthcare Institute; Louise Scherer Knight, Director, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Roanne Osborne-Gaskin, M.D., Senior Medical Director, MDWise, Inc.; Cathy Phan, Outreach and Education Coordinator, Asian American Health Coalition DBA HOPE Clinic; Kamilah Pickett, Litigation Support, Independent Contractor; Brendan Riley, Outreach and Enrollment Coordinator, NC Community Health Center Association; Alvia Siddiqi, Medicaid Managed Care Community Network (MCCN) Medical Director, Advocate Physician Partners, Carla Smith, Executive Vice President, Healthcare Information and Management Systems Society (HIMSS); Tobin Van Ostern, Vice President and Co-Founder, Young Invincibles Advisors; and Paula Villescaz, Senior Consultant, Assembly Health Committee, California State Legislature. II. Provisions of This Notice In accordance with section 10(a) of the FACA, this notice announces a meeting of the APOE. The agenda for the September 13, 2017 meeting will include the following: • Welcome and listening session with CMS leadership • Recap of the previous (March 22, 2017) meeting • Review CMS programs and initiatives • Provide an opportunity for public comment • Summarize the meeting and review recommendations and next steps E:\FR\FM\11AUN1.SGM 11AUN1 Federal Register / Vol. 82, No. 154 / Friday, August 11, 2017 / Notices Individuals or organizations that wish to make a 5-minute oral presentation on an agenda topic should submit a written copy of the oral presentation to the DFO at the address listed in the ADDRESSES section of this notice by the date listed in the DATES section of this notice. The number of oral presentations may be limited by the time available. Individuals not wishing to make an oral presentation may submit written comments to the DFO at the address listed in the ADDRESSES section of this notice by the date listed in the DATES section of this notice. III. Security and Building The meeting is open to the public, but attendance is limited to the space available. Persons wishing to attend this meeting must register by contacting the DFO at the address listed in the ADDRESSES section of this notice or by telephone at the number listed in the FOR FURTHER INFORMATION CONTACT asabaliauskas on DSKBBXCHB2PROD with NOTICES section of this notice by the date specified in the DATES section of this notice. Since this meeting will be held in a Federal Government Building, the Hubert H. Humphrey Building, Federal security measures are applicable. In planning your arrival time, we recommend allowing additional time to clear security. To gain access to the building, participants will be required to show a government-issued photo identification (for example, driver’s license or passport), and must be listed on an approved security list before persons are permitted entrance. Persons not registered in advance will not be permitted into the Hubert H. Humphrey Building and will not be permitted to attend the Panel meeting. All persons entering the building must pass through a metal detector. In addition, all items brought to the Hubert H. Humphrey Building, whether personal or for the purpose of presentation, are subject to inspection. We cannot assume responsibility for coordinating the receipt, transfer, transport, storage, set-up, safety, or timely arrival of any personal belongings or items used for the purpose of presentation. Authority: 42 U.S.C. 217a, sec. 222 of the Public Health Service Act, as amended; 42 U.S.C. 1314(f), sec. 1114(f) of the Social Security Act; and Public Law 92–463, as amended (5 U.S.C. App. 2). Dated: August 2, 2017. Seema Verma, Administrator, Centers for Medicare & Medicaid Services. [FR Doc. 2017–16979 Filed 8–10–17; 8:45 am] BILLING CODE 4120–01–P VerDate Sep<11>2014 17:18 Aug 10, 2017 Jkt 241001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel, Macula Degenerative Diseases Date: August 23, 2017. Time: 1:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Nataliya Gordiyenko, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5202, MSC 7846, Bethesda, MD 20892, 301.435.1265, gordiyenkon@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: August 7, 2017. Sylvia L. Neal, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2017–16914 Filed 8–10–17; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Secretary; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Muscular Dystrophy Coordinating Committee (MDCC). The meeting will be open to the public and accessible by live webcast. Attendance is limited to space available. PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 37595 Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Committee: Muscular Dystrophy Coordinating Committee. Type of meeting: Open Meeting. Date: October 4, 2017. Time: 8:30 a.m. to 4:30 p.m. *Eastern Time*—Approximate end time. Agenda: Agenda: The purpose of this meeting is to bring together committee members, representing government agencies, patient advocacy groups, other voluntary health organizations, and patients and their families to update one another on progress relevant to the Action Plan for the Muscular Dystrophies and to coordinate activities and discuss gaps and opportunities leading to better understanding of the muscular dystrophies, advances in treatments, and improvements in patients’ and their families’ lives. Prior to the meeting, an agenda will be posted to the MDCC meeting registration Web site: https://meetings.ninds.nih.gov/ meetings/Oct42017/. Registration: To register, please go to: https://meetings.ninds.nih.gov/meetings/ Oct42017/. Webcast Live: For those not able to attend in person, this meeting will be webcast at: http://videocast.nih.gov/. Place: Neuroscience Center, Conference Room C/D, 6001 Executive Boulevard, Rockville, Maryland 20852. Contact Person: Glen H. Nuckolls, Ph.D., Executive Secretary, Muscular Dystrophy Coordinating Committee, National Institute of Neurological Disorders and Stroke, NIH, 6001 Executive Boulevard, NSC 2203, Bethesda, MD 20892, (301) 496–5745, glen.nuckolls@ninds.nih.gov. Any member of the public interested in presenting oral comments to the committee may notify the Contact Person listed on this notice at least 10 days in advance of the meeting. Interested individuals and representatives of organizations may submit a letter of intent, a brief description of the organization represented, and a short description of the oral presentation. Only one representative of an organization may be allowed to present oral comments and if accepted by the committee, presentations may be limited to five minutes. Both printed and electronic copies are requested for the record. In addition, any interested person may file written comments with the committee by forwarding their statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. All visitors must go through a security check at the building entrance to receive a visitor’s badge. A government issued photo ID is required. Further information can be found at the registration Web site: https:// meetings.ninds.nih.gov/meetings/Oct42017/. (Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, E:\FR\FM\11AUN1.SGM 11AUN1

Agencies

[Federal Register Volume 82, Number 154 (Friday, August 11, 2017)]
[Notices]
[Pages 37593-37595]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-16979]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Medicare & Medicaid Services

[CMS-7046-N]


Health Insurance Marketplace[hairsp]\SM\, Medicare, Medicaid, and 
Children's Health Insurance Programs; Meeting of the Advisory Panel on 
Outreach and Education (APOE), September 13, 2017

AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice announces the next meeting of the Advisory Panel 
on Outreach and Education (APOE) (the Panel) in accordance with the 
Federal Advisory Committee Act. The Panel advises and makes 
recommendations to the Secretary of the U.S. Department of Health and 
Human Services (HHS) and the Administrator of the Centers for Medicare 
& Medicaid Services (CMS) on opportunities to enhance the effectiveness 
of consumer education strategies concerning the Health Insurance 
Marketplace[hairsp]\SM\, Medicare, Medicaid, and the Children's Health 
Insurance Program (CHIP). This meeting is open to the public.

DATES: Meeting Date: Wednesday, September 13, 2017, 8:30 a.m. to 4:00 
p.m. eastern daylight time (e.d.t).
    Deadline for Meeting Registration, Presentations, Special 
Accommodations and Comments: Wednesday, August 30, 2017, 5:00 p.m. 
(e.d.t.).

ADDRESSES: Meeting Location: U.S. Department of Health & Human 
Services, Hubert H. Humphrey Building, 200 Independence Avenue SW., 
Room 505A, Conference Room, Washington, DC 20201.
    Presentations and Written Comments: Presentations and written 
comments should be submitted to: Thomas Dudley, Designated Federal 
Official (DFO), Office of Communications, Centers for Medicare & 
Medicaid Services, 7500 Security Boulevard, Mailstop S1-05-06, 
Baltimore, MD 21244-1850 or via email at Thomas.Dudley@cms.hhs.gov.
    Registration: The meeting is open to the public, but attendance is 
limited to the space available. Persons wishing to attend this meeting 
must register at the Web site https://www.regonline.com/apoesept2017meeting or by contacting the DFO as listed in the FOR 
FURTHER INFORMATION CONTACT section of this notice, by the date listed 
in the DATES section of this notice. Individuals requiring sign 
language interpretation or other special accommodations should contact 
the DFO at the address listed in the ADDRESSES section of this notice 
by the date listed in the DATES section of this notice.

FOR FURTHER INFORMATION CONTACT: Thomas Dudley, Designated Federal 
Official, Office of Communications, CMS, 7500 Security Boulevard, Mail 
Stop S1-05-06, Baltimore, MD 21244-1850, 410-786-1442, email 
Thomas.Dudley@cms.hhs.gov. Additional information about the APOE is 
available on the Internet at: http://www.cms.gov/Regulations-and-Guidance/Guidance/FACA/APOE.html. Press inquiries are handled through 
the CMS Press Office at (202) 690-6145.

SUPPLEMENTARY INFORMATION: 

I. Background

    The Advisory Panel for Outreach and Education (APOE) (the Panel) is 
governed by the provisions of Federal Advisory Committee Act (FACA) 
(Pub. L. 92-463), as amended (5 U.S.C. App. 2), which sets forth 
standards for the formation and use of federal advisory committees. The 
Panel is authorized by section 1114(f) of the Social Security Act (42 
U.S.C. 1314(f)) and section 222 of the Public Health Service Act (42 
U.S.C. 217a).
    The Secretary of the U.S. Department of Health and Human Services 
(HHS) (the Secretary) signed the charter establishing the Citizen's 
Advisory Panel on Medicare Education \1\ (the

[[Page 37594]]

predecessor to the APOE) on January 21, 1999 (64 FR 7899, February 17, 
1999) to advise and make recommendations to the Secretary and the 
Administrator of the Centers for Medicare & Medicaid Services (CMS) on 
the effective implementation of national Medicare education programs, 
including with respect to the Medicare+Choice (M+C) program added by 
the Balanced Budget Act of 1997 (Pub. L. 105-33).
---------------------------------------------------------------------------

    \1\ We note that the Citizen's Advisory Panel on Medicare 
Education is also referred to as the Advisory Panel on Medicare 
Education (65 FR 4617). The name was updated in the Second Amended 
Charter approved on July 24, 2000.
---------------------------------------------------------------------------

    The Medicare Modernization Act of 2003 (MMA) (Pub. L. 108-173) 
expanded the existing health plan options and benefits available under 
the M+C program and renamed it the Medicare Advantage (MA) program. We 
have had substantial responsibilities to provide information to 
Medicare beneficiaries about the range of health plan options available 
and better tools to evaluate these options. The successful MA program 
implementation required CMS to consider the views and policy input from 
a variety of private sector constituents and to develop a broad range 
of public-private partnerships.
    In addition, Title I of the MMA authorized the Secretary and the 
Administrator of CMS (by delegation) to establish the Medicare 
prescription drug benefit. The drug benefit allows beneficiaries to 
obtain qualified prescription drug coverage. In order to effectively 
administer the MA program and the Medicare prescription drug benefit, 
we have substantial responsibilities to provide information to Medicare 
beneficiaries about the range of health plan options and benefits 
available, and to develop better tools to evaluate these plans and 
benefits.
    The Affordable Care Act (Patient Protection and Affordable Care 
Act, Public Law 111-148, and Health Care and Education Reconciliation 
Act of 2010, Public Law 111-152) expanded the availability of other 
options for health care coverage and enacted a number of changes to 
Medicare as well as to Medicaid and the Children's Health Insurance 
Program (CHIP). Qualified individuals and qualified employers are now 
able to purchase private health insurance coverage through a 
competitive marketplace, called an Affordable Insurance Exchange (also 
called Health Insurance Marketplace\SM\,\2\ or Marketplace\SM\). In 
order to effectively implement and administer these changes, we must 
provide information to consumers, providers, and other stakeholders 
through education and outreach programs regarding how existing programs 
will change and the expanded range of health coverage options 
available, including private health insurance coverage through the 
Marketplace\SM\. The APOE allows us to consider a broad range of views 
and information from interested audiences in connection with this 
effort and to identify opportunities to enhance the effectiveness of 
education strategies concerning the Affordable Care Act.
---------------------------------------------------------------------------

    \2\ Health Insurance Marketplace\SM\ and Marketplace\SM\ are 
service marks of the U.S. Department of Health & Human Services.
---------------------------------------------------------------------------

    The scope of this panel also includes advising on issues pertaining 
to the education of providers and stakeholders with respect to the 
Affordable Care Act and certain provisions of the Health Information 
Technology for Economic and Clinical Health (HITECH) Act enacted as 
part of the American Recovery and Reinvestment Act of 2009 (ARRA).
    On January 21, 2011, the Panel's charter was renewed and the Panel 
was renamed the Advisory Panel for Outreach and Education. The Panel's 
charter was most recently renewed on January 19, 2017, and will 
terminate on January 19, 2019 unless renewed by appropriate action.
    Under the current charter, the APOE will advise the Secretary and 
the Administrator on optimal strategies for the following:
     Developing and implementing education and outreach 
programs for individuals enrolled in, or eligible for, Medicare, 
Medicaid, and the Children's Health Insurance Program (CHIP), or 
coverage available through the Health Insurance Marketplace\SM\ and 
other CMS programs.
     Enhancing the federal government's effectiveness in 
informing Health Insurance Marketplace\SM\, Medicare, Medicaid, and 
CHIP consumers, issuers, providers, and stakeholders, through education 
and outreach programs, on issues regarding these programs, including 
the appropriate use of public-private partnerships to leverage the 
resources of the private sector in educating beneficiaries, providers, 
and stakeholders.
     Expanding outreach to vulnerable and underserved 
communities, including racial and ethnic minorities, in the context of 
Health Insurance Marketplace\SM\, Medicare, Medicaid, and CHIP 
education programs and other CMS programs as designated.
     Assembling and sharing an information base of ``best 
practices'' for helping consumers evaluate health coverage options.
     Building and leveraging existing community infrastructures 
for information, counseling, and assistance.
     Drawing the program link between outreach and education, 
promoting consumer understanding of health care coverage choices, and 
facilitating consumer selection/enrollment, which in turn support the 
overarching goal of improved access to quality care, including 
prevention services, envisioned under the Affordable Care Act.
    The current members of the Panel are: Kellan Baker, Associate 
Director, Center for American Progress; Robert Blancato, President, 
Matz, Blancato & Associates; Dale Blasier, Professor of Orthopaedic 
Surgery, Department of Orthopaedics, Arkansas Children's Hospital; 
Deborah Britt, Executive Director of Community & Public Relations, 
Piedmont Fayette Hospital; Deena Chisolm, Associate Professor of 
Pediatrics & Public Health, The Ohio State University, Nationwide 
Children's Hospital; Josephine DeLeon, Director, Anti-Poverty 
Initiatives, Catholic Charities of California; Robert Espinoza, Vice 
President of Policy, Paraprofessional Healthcare Institute; Louise 
Scherer Knight, Director, The Sidney Kimmel Comprehensive Cancer Center 
at Johns Hopkins; Roanne Osborne-Gaskin, M.D., Senior Medical Director, 
MDWise, Inc.; Cathy Phan, Outreach and Education Coordinator, Asian 
American Health Coalition DBA HOPE Clinic; Kamilah Pickett, Litigation 
Support, Independent Contractor; Brendan Riley, Outreach and Enrollment 
Coordinator, NC Community Health Center Association; Alvia Siddiqi, 
Medicaid Managed Care Community Network (MCCN) Medical Director, 
Advocate Physician Partners, Carla Smith, Executive Vice President, 
Healthcare Information and Management Systems Society (HIMSS); Tobin 
Van Ostern, Vice President and Co-Founder, Young Invincibles Advisors; 
and Paula Villescaz, Senior Consultant, Assembly Health Committee, 
California State Legislature.

II. Provisions of This Notice

    In accordance with section 10(a) of the FACA, this notice announces 
a meeting of the APOE. The agenda for the September 13, 2017 meeting 
will include the following:

 Welcome and listening session with CMS leadership
 Recap of the previous (March 22, 2017) meeting
 Review CMS programs and initiatives
 Provide an opportunity for public comment
 Summarize the meeting and review recommendations and next 
steps


[[Page 37595]]


    Individuals or organizations that wish to make a 5-minute oral 
presentation on an agenda topic should submit a written copy of the 
oral presentation to the DFO at the address listed in the ADDRESSES 
section of this notice by the date listed in the DATES section of this 
notice. The number of oral presentations may be limited by the time 
available. Individuals not wishing to make an oral presentation may 
submit written comments to the DFO at the address listed in the 
ADDRESSES section of this notice by the date listed in the DATES 
section of this notice.

III. Security and Building

    The meeting is open to the public, but attendance is limited to the 
space available. Persons wishing to attend this meeting must register 
by contacting the DFO at the address listed in the ADDRESSES section of 
this notice or by telephone at the number listed in the FOR FURTHER 
INFORMATION CONTACT section of this notice by the date specified in the 
DATES section of this notice.
    Since this meeting will be held in a Federal Government Building, 
the Hubert H. Humphrey Building, Federal security measures are 
applicable. In planning your arrival time, we recommend allowing 
additional time to clear security. To gain access to the building, 
participants will be required to show a government-issued photo 
identification (for example, driver's license or passport), and must be 
listed on an approved security list before persons are permitted 
entrance. Persons not registered in advance will not be permitted into 
the Hubert H. Humphrey Building and will not be permitted to attend the 
Panel meeting.
    All persons entering the building must pass through a metal 
detector. In addition, all items brought to the Hubert H. Humphrey 
Building, whether personal or for the purpose of presentation, are 
subject to inspection. We cannot assume responsibility for coordinating 
the receipt, transfer, transport, storage, set-up, safety, or timely 
arrival of any personal belongings or items used for the purpose of 
presentation.

    Authority: 42 U.S.C. 217a, sec. 222 of the Public Health Service 
Act, as amended; 42 U.S.C. 1314(f), sec. 1114(f) of the Social 
Security Act; and Public Law 92-463, as amended (5 U.S.C. App. 2).

    Dated: August 2, 2017.
Seema Verma,
Administrator, Centers for Medicare & Medicaid Services.
[FR Doc. 2017-16979 Filed 8-10-17; 8:45 am]
 BILLING CODE 4120-01-P